A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes

• Published in: Journal of controlled release Vol. 356; pp. 386 - 401
• Main Authors: Agallou, Maria, Margaroni, Maritsa, Tsanaktsidou, Evgenia, Badounas, Fotis, Kammona, Olga, Kiparissides, Costas, Karagouni, Evdokia
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2023
• Subjects: Adjuvant; Adjuvants, Immunologic; Animals; Antigens; CD8-Positive T-Lymphocytes; Dendritic Cells; Imiquimod; Immunity, Humoral; Innate response; Liposome; Liposomes - chemistry; Lymph Nodes - metabolism; Mice; Mice, Inbred C57BL; Subunit chimeric vaccine; Vaccines - pharmacology; Liposome; Innate response; Adjuvant; Dendritic cells; Imiquimod; Subunit chimeric vaccine
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2023.03.006

Subunit proteins provide a safe source of antigens for vaccine development especially for intracellular infections which require the induction of strong cellular immune responses. However, those antigens are often limited by their low immunogenicity. In order to achieve effective immune responses, they should be encapsulated into a stable antigen delivery system combined with an appropriate adjuvant. As such cationic liposomes provide an efficient platform for antigen delivery. In the present study, we describe a liposomal vaccine platform for co-delivery of antigens and adjuvants able to elicit strong antigen-specific adaptive immune responses. Liposomes are composed of the cationic lipid dimethyl dioctadecylammonium bromide (DDAB), cholesterol (CHOL) and oleic acid (OA). Physicochemical characterization of the formulations showed that their size was in the range of ∼250 nm with a positive zeta potential which was affected in some cases by the enviromental pH facilitating endosomal escape of potential vaccine cargo. In vitro, liposomes were effectively taken up by bone marrow dendritic cells (BMDCs) and when encapsulated IMQ they promoted BMDCs maturation and activation. Upon in vivo intramuscular administration, liposomes' active drainage to lymph nodes was mediated by DCs, B cells and macrophages. Thus, mice immunization with liposomes having encapsulated LiChimera, a previously characterized anti-leishmanial antigen, and IMQ elicited infiltration of CD11blow DCs populations in draining LNs followed by increased antigen-specific IgG, IgG2a and IgG1 levels production as well as indcution of antigen-specific CD4+ and CD8+ T cells. Collectively, the present work provides a proof-of-concept that cationic liposomes composed of DDAB, CHOL and OA adjuvanted with IMQ provide an efficient delivery platform for protein antigens able to induce strong adaptive immune responses via DCs targeting and induction of maturation. [Display omitted] •Cationic liposomes were prepared for efficient subunit vaccine delivery.•Liposomes promoted antigen delivery to draining lymph nodes via APCs trafficking.•IMQ-loaded liposomes triggered DCs maturation.•Mice immunization induced antigen-specific humoral and cellular immune responses.